Preimplantation Genetics Diagnosis Market
As per the report published by Allied Market Research, the global Preimplantation Genetics Diagnosis Market was accounted for $81.52 billion in 2020, and is estimated to reach $217.19 billion by 2030, growing at a CAGR of 10.4% from 2021 to 2030.
Increase in consumption of alcohol, drug, poor diet, and smoking, surge in stress among people, and rise in health problems associated with hormones have boosted the growth of the global preimplantation genetics diagnosis (PGD) market. However, high costs involved for various diagnosis hamper the market growth. On the contrary, increase in number of patients suffering from genetic disorders and surge in hereditary diseases are expected to open new opportunities in the future.
Request Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1470
Depending on test type, the market is segmented on the basis of chromosomal abnormalities, aneuploidy, X-linked diseases, single gene disorders, human leukocyte antigens (HLA) typing, gender selection, and others. The chromosomal abnormalities segment accounted for the highest market share in 2020 and single gene disorders is expected to witness significant growth during the forecast period, owing to rise in number of patients suffering from genetic disorders. The market is mainly driven by increase in awareness regarding embryo genetic testing. In addition, rise in infertility rate and surge in hereditary diseases positively influenced the growth of the market. However, high costs involved for various diagnosis can hinder the growth of preimplantation genetics diagnosis market size.
In 2020, North America dominated the global PGD market, in terms of revenue, accounting for around 40% share of the radiology information system industry, followed by Europe and Asia-Pacific. Moreover, the market in Asia-Pacific is growing with high CAGR, owing to increased adoption of in vitro fertilization (IVF).
Market Segmentation:
By Test Type:
Chromosomal Abnormalities
Aneuploidy
X-linked diseases
Single Gene Disorders
HLA Typing
Gender selection
Others
By Region:
Asia-Pacific (China, Japan, India, South Korea, Rest Of Asia Pacific)
LAMEA (Latin America, Middle East, Africa)
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Rest of Europe)
Key Market Players:
Agilent Technologies, Inc.
CeGaT GmbH
Illumina Inc., Illumina Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Natera Inc.
PacGenomics
PerkinElmer, Inc.
Quest Diagnostics Inc.
Reproductive Genetic Innovations (RGI)
𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:
Microsurgery Market is growing at a CAGR of 6% from 2024 to 2033
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
